-
Dr. Huibiao Zhang: ThreeOsimertinib Adjuvant Studies Shine at ELCC, Adding New Evidence for Early-Stage Lung Cancer Treatment
-
Dr. Zhengfei Zhu: Can EGFR-TKI Combined with Local Consolidative Therapy Achieve “1+1＞2”?
-
The urology team of West China Hospital has selected multiple studies for the 2023 EAU conference
-
Two Studies of Dr. Yong Xu’s Teamat the 2023 EAU Congress, Provided New Insights into Prostate Cancer Biopsies
-
Dr. Jun Ma: On the immunotherapeutic progress and future trends for acute lymphoblastic leukemia based on the studies at EHA 2023
-
Two renal cancer-related studies by Dr. KanGong ‘s team selected for the 2023 EAU Annual Meeting
-
Dr. HuiqiangHuang: Just around the corner! Extranodal NK/T-cell lymphoma is ushering in the era of immunotherapy.
-
Dr. Peihua Lu: Targeting CD7 CAR-T Cells Holds Promise for Treating Central Nervous System T-Cell Lymphoblastic Lymphoma/Leukemia
-
Dr. QianJiang: Reduced Dosage without Reducing Efficacy, Better Quality of Life for Patients
Connecting Medical Expertise through Media